S. Ashley

发表

Factors determining outcome after third line chemotherapy for metastatic breast cancer.

S. Johnston, U. Banerji, I. Smith, 2007, Breast.

Management of anemia in patients receiving chemotherapy.

M. O'Brien, J. Waters, S. Ashley, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.

J. Yarnold, I. Smith, H. Ford, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer?

W. Allum, I. Smith, A. Ring, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiofrequency ablation is a feasible therapeutic option in the multi modality management of sarcoma.

Robin L. Jones, C. Fisher, I. Judson, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Clinical Benefit of Second-Line Palliative Chemotherapy in Advanced Soft-Tissue Sarcoma

Robin L. Jones, C. Fisher, I. Judson, 2010, Sarcoma.

Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer.

N M deSouza, C. Parker, C. Fisher, 2008, Clinical radiology.

Magnetic resonance spectroscopy in the evaluation of neurotoxicity following cranial irradiation for childhood cancer.

D. Tait, J. Hopewell, M. Leach, 2000, The British journal of radiology.

Serum angiogenic profile of patients with glioblastoma identifies distinct tumor subtypes and shows that TIMP-1 is a prognostic factor.

M. Papadopoulos, I. Giddings, B. Bell, 2011, Neuro-oncology.

Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer.

P. Ellis, S. Ebbs, M. Baum, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Study Clinical Beneﬁt of Second-Line Palliative Chemotherapy in Advanced Soft-Tissue Sarcoma

Robin L. Jones, C. Fisher, I. Judson, 2013 .

Gefitinib in patients with non-small cell lung cancer (NSCLC): The Royal Marsden experience.

S. Banerjee, T. Eisen, C. Harper-wynne, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Basal-like breast carcinomas: clinical outcome and response to chemotherapy

A. Ashworth, S. Lakhani, J. Reis-Filho, 2006, Journal of Clinical Pathology.

Early assessment of MCV to predict clinical outcome in patients with advanced gastrointestinal stromal tumors (GIST) receiving imatinib.

Robin L. Jones, I. Judson, D. Olmos, 2012 .

Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification.

A. Órfão, A. Porwit, M. Béné, 2011, Blood.

A study of factors determining outcome of patients receiving third line chemotherapy for metastatic breast cancer: The Royal Marsden Hospital experience.

S. Johnston, U. Banerji, I. Smith, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.